HARNESSING ECOLOGY FOR HEALTH

We design bacterial therapeutics to prevent infectious disease.

We would appreciate you taking a few moments of your time to fill out our survey below.

TAKE OUR SURVEY

We believe our machine learning and bioinformatics pipeline can design bacterial therapeutics to prevent the incidence of infectious disease in humans, animals and plants.

Our in silico screening technology increase the speed to market for bacterial therapeutics. We circumvent the cost and time burden of large in vitro screens and, do not rely on data from expensive association studies.

MARKET DISCOVERY

Initial Concept

Our initial target disease and proof-of-concept is thrush, where 5-10% of cases reoccur after each antifungal course. Our approach aims to provide long-term relief that current strategies cannot deliver.

Stakeholders

We wish to speak to Pharma/biotech companies who are looking for solutions to early stage therapeutic discovery and who are interested in diversifying current technology while keeping up to date with innovations in treatment and prevention of infections.